Finance

Lists
002007:SHE
Hualan Biological Engineering Inc
CNÂ¥13.04
+0.69%
(+0.090) 1D
Sep 4, 3:04:51 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002007...
Open
CNÂ¥12.95
High
CNÂ¥13.13
Low
CNÂ¥12.94
Mkt. cap
23.64B
Avg. vol.
13.46M
Volume
7.89M
Dividend
7.67%
Quarterly dividend
CNÂ¥0.25
Ex-dividend date
Jun 15, 2026
P/E ratio
29.47
52-wk high
CNÂ¥17.09
52-wk low
CNÂ¥11.72
EPS
CNÂ¥0.44
Shares outstanding
1.83B
No. of employees
4K
Open
CNÂ¥12.95
High
CNÂ¥13.13
Low
CNÂ¥12.94
Mkt. cap
23.64B
Avg. vol.
13.46M
Volume
7.89M
Dividend
7.67%
Quarterly dividend
CNÂ¥0.25
Ex-dividend date
Jun 15, 2026
P/E ratio
29.47
52-wk high
CNÂ¥17.09
52-wk low
CNÂ¥11.72
EPS
CNÂ¥0.44
Shares outstanding
1.83B
No. of employees
4K
About Hualan Biological Engineering Inc
CEO-
Employees4.12K
FoundedMar 30, 1992
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.58B
1.22B
762.11M
804.53M
Cost of goods sold
587.72M
582.94M
379.63M
451.77M
Cost of revenue
587.72M
582.94M
379.63M
451.77M
Research and development expenses
73.29M
102.82M
59.51M
65.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
517.66M
246.60M
94.27M
155.42M
Operating expense
649.06M
383.03M
125.15M
234.79M
Total operating expenses
1.24B
965.98M
504.77M
686.55M
Operating income
343.91M
250.16M
257.34M
117.97M
Other non operating income
-35.64M
35.34M
-9.16M
8.89M
EBT including unusual items
360.97M
200.93M
289.50M
184.50M
EBT excluding unusual items
316.52M
261.62M
282.39M
193.46M
Income tax expense
55.96M
28.64M
46.91M
31.90M
Effective tax rate
15.50%
14.25%
16.20%
17.29%
Other operating expenses
10.93M
12.16M
12.96M
11.36M
Net income
268.56M
155.98M
230.35M
153.01M
Net profit margin
16.99%
12.83%
30.23%
19.02%
Earnings per share
-
-
-
-
Interest and investment income
9.47M
-
34.31M
66.62M
Interest expense
-892.85K
-24.12M
-95.52K
-95.52K
Net interest expenses
8.58M
-24.12M
34.22M
66.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
408.93M
318.63M
325.81M
186.11M
Gain or loss from assets sale
-21.45K
-2.89M
-
696.14K
AI content may include mistakes. Learn more
Google apps